(Q38442612)

3 September 2017

title

Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemia (English)

1 reference

3 September 2017

1 reference

Weisser M

1

1 reference

3 September 2017

Kern W

2

1 reference

3 September 2017

Rauhut S

3

1 reference

3 September 2017

Schoch C

4

1 reference

3 September 2017

Hiddemann W

5

1 reference

3 September 2017

Haferlach T

6

1 reference

3 September 2017

Schnittger S

7

1 reference

3 September 2017

publication date

1 August 2005

1 reference

3 September 2017

1 reference

3 September 2017

volume

19

1 reference

3 September 2017

issue

8

1 reference

3 September 2017

page(s)

1416-1423

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403809

3 September 2017

exact match

0 references

cites work

New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFBMYH11+ acute myeloid leukemia based on quantification of fusion transcripts.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

WT1 as a universal marker for minimal residual disease detection and quantification in myeloid leukemias and in myelodysplastic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients - results from a single-centre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

Wilms tumor gene expression in acute myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

Prognostic significance of quantitative analysis of WT1 gene transcripts by competitive reverse transcription polymerase chain reaction in acute leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

7 January 2021

Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

7 January 2021

WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

7 January 2021

Wilms' tumor gene product WT1 arrests macrophage differentiation of HL-60 cells through its zinc-finger domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

7 January 2021

Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

7 January 2021

Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

7 January 2021

The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

7 January 2021

Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

7 January 2021

Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

7 January 2021

6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

7 January 2021

Fluorescent 5'-exonuclease assay for the absolute quantification of Wilms' tumour gene (WT1) mRNA: implications for monitoring human leukaemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

7 January 2021

The detection of wt-1 transcripts is not associated with an increased leukemic relapse rate in patients with acute leukemia after allogeneic bone marrow or peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403809

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403809

1 reference

Dimensions Publication ID

3 September 2017

1040786175

0 references

1 reference